Nov 09, 2022
The federal government issued interim final rules for these requirements with reporting for 2020 and 2021 due by December 27, 2022, and then by June 1 of each year thereafter.
For plans with Prescription Drug Benefits, EmblemHealth will implement these reporting requirements in a timely manner and plans to submit aggregate data by state and market segment.
Visit EmblemHealth's CAA page to learn how Emblem is handling all reporting related to Transparency in Coverage requirements.